Congress Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,475
Closed -$1.08M 1189
2025
Q1
$1.08M Sell
2,475
-150
-6% -$60.2K 0.01% 619
2024
Q4
$969K Buy
2,625
+476
+22% +$199K 0.01% 524
2024
Q3
$1.12M Buy
2,149
+443
+26% +$237K 0.01% 500
2024
Q2
$925K Sell
1,706
-107
-6% -$56.6K 0.01% 439
2024
Q1
$941K Sell
1,813
-260
-13% -$129K 0.02% 381
2023
Q4
$978K Buy
2,073
+359
+21% +$166K 0.02% 394
2023
Q3
$746K Buy
1,714
+8
+0.5% +$3.63K 0.02% 405
2023
Q2
$758K Buy
1,706
+18
+1% +$8.3K 0.02% 369
2023
Q1
$777K Sell
1,688
-230
-12% -$109K 0.02% 371
2022
Q4
$984K Buy
1,918
+914
+91% +$464K 0.03% 339
2022
Q3
$456K Sell
1,004
-1
-0.1% -$478 0.01% 419
2022
Q2
$485K Sell
1,005
-27
-3% -$13.4K 0.01% 413
2022
Q1
$507K Buy
1,032
+44
+4% +$20.1K 0.01% 443
2021
Q4
$458K Buy
+988
New +$416K 0.01% 478

Other funds holding ELV

Congress Wealth Management's ELV Position: Q2 2025 in Review

Congress Wealth Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 2,475 shares — an estimated $1.08M sold.

Congress Wealth Management first reported a position in ELV in Q4 2021 and held it in 14 quarters. The position peaked at $1.12M in Q3 2024. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Congress Wealth Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Congress Wealth Management sold 2,475 Elevance Health shares in Q2 2025, an estimated $1.08M.
  • Congress Wealth Management first reported a position in Elevance Health in Q4 2021 and held it in 14 quarters.
  • Congress Wealth Management's Elevance Health position peaked at $1.12M in Q3 2024.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.